期刊
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
卷 1855, 期 2, 页码 144-154出版社
ELSEVIER
DOI: 10.1016/j.bbcan.2015.01.001
关键词
5-Hydroxymethylcytosine; DNA methylation; Cancer; TET; IDH
资金
- Netherlands Institute for Regenerative Medicine (NIRM) [DFES1029161]
- ERA-NET/TRANSCAN/FP7 [KUN2013-6395]
The epigenetic mark 5-hydroxymethylcytosine (5hmC) has gained interest since 2009, when it was discovered that Ten-Eleven-Translocation (TET) proteins catalyze the conversion of 5-methylcytosine (5mC) into 5hmC. This conversion appears to be an intermediate step in the active DNA demethylation pathway. Factors that regulate DNA hydroxymethylation are frequently affected in cancer, leading to deregulated 5hmC levels. In this review, we will discuss the regulation of DNA hydroxymethylation, defects in this pathway in cancer, and novel therapies that may correct deregulated (hydroxy)methylation of DNA. (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据